Wu T-C相关文献与解析，生知库 | 链接生命科学的每一步

A randomized pilot study of HPV16 L2E7E6 fusion protein vaccination site post-treatment for HPV16+ cervical cancer

一项关于HPV16 L2E7E6融合蛋白疫苗接种部位治疗后HPV16阳性宫颈癌的随机试点研究

doi:10.1016/j.ygyno.2025.08.006

Gaillard, Stéphanie; Alvarez, Jade; Zhang, Tianbei; Wang, Hao; Tsai, Hua-Ling; Cope, Leslie; Deery, Amy; Palande, Vikrant; Lee, Chi-Fen; Fader, Amanda N; Huh, Warner K; Arend, Rebecca C; Liang, Margaret I; Straughn, J Michael Jr; Vang, Russell; Ostrander, Darin; Horner, Karen; Zhang, Li; Singh, Dipika; Smith, Kellie N; Wu, T C; Leath, Charles A 3rd; Roden, Richard B S

Molecular targets and strategies in the development of nucleic acid cancer vaccines: from shared to personalized antigens

核酸癌症疫苗研发中的分子靶点和策略：从共享抗原到个性化抗原

期刊:Journal of Biomedical Science

影响因子:12.1

doi:10.1186/s12929-024-01082-x

Chi, Wei-Yu; Hu, Yingying; Huang, Hsin-Che; Kuo, Hui-Hsuan; Lin, Shu-Hong; Kuo, Chun-Tien Jimmy; Tao, Julia; Fan, Darrell; Huang, Yi-Min; Wu, Annie A; Hung, Chien-Fu; Wu, T-C

Arginine-linked HPV-associated E7 displaying bacteria-derived outer membrane vesicles as a potent antigen-specific cancer vaccine

精氨酸连接的HPV相关E7蛋白展示细菌来源的外膜囊泡，作为一种强效的抗原特异性癌症疫苗

期刊:Journal of Translational Medicine

影响因子:7.5

doi:10.1186/s12967-024-05195-7

Wang, Suyang; Chen, Chao-Cheng; Hu, Ming-Hung; Cheng, Michelle; Tu, Hsin-Fang; Tsai, Ya-Chea; Yang, Jr-Ming; Wu, T C; Huang, Chuan-Hsiang; Hung, Chien-Fu

Salmonella immunotherapy engineered with highly efficient tumor antigen coating establishes antigen-specific CD8+ T cell immunity and increases in antitumor efficacy with type I interferon combination therapy

采用高效肿瘤抗原包被的沙门氏菌免疫疗法可建立抗原特异性CD8+ T细胞免疫，并增强与I型干扰素联合疗法的抗肿瘤疗效。

期刊:Oncoimmunology

影响因子:6.3

doi:10.1080/2162402X.2023.2298444

Wang, Suyang; Cheng, Michelle; Chen, Chao-Cheng; Chang, Chia-Yu; Tsai, Ya-Chea; Yang, Jr-Ming; Wu, T C; Huang, Chuan-Hsiang; Hung, Chien-Fu

Uterine MEIS1::NCOA2 Fusion Sarcoma With Lung Metastasis: A Case Report and Review of the Literature

子宫MEIS1::NCOA2融合肉瘤伴肺转移：病例报告及文献复习

期刊:International Journal of Gynecological Pathology

影响因子:1.7

doi:10.1097/PGP.0000000000000951

Xing, Deyin; Meyer, Christian F; Gross, John M; Argani, Pedram; Hung, Chien-Fu; Wu, T-C; Vang, Russell; Armstrong, Deborah K; Gaillard, Stéphanie L

NCOA2

发表日期：2024

文献求助收藏

Sidedness and addition of chemotherapy associated with treatment outcomes of regorafenib for metastatic colorectal cancer: a population-wide cohort study

转移性结直肠癌瑞戈非尼治疗结果与肿瘤侧别及是否联合化疗的相关性：一项基于人群的队列研究

期刊:

影响因子:

doi:10.1016/j.esmogo.2024.100052

Wu, T-C; Liang, Y-H; Chen, K-H; Shao, Y-Y

Profiling of VEGF Receptors and Immune Checkpoints in Recurrent Respiratory Papillomatosis

复发性呼吸道乳头状瘤病中 VEGF 受体和免疫检查点的分析

期刊:Laryngoscope

影响因子:

doi:10.1002/lary.31253

Lam, Brandon; Miller, Jonas; Kung, Yu Jui; Wu, T C; Hung, Chien-Fu; Roden, Richard B S; Best, Simon R

Immune responses, therapeutic anti-tumor effects, and tolerability upon therapeutic HPV16/18 E6/E7 DNA vaccination via needle-free biojector

通过无针生物注射器进行治疗性 HPV16/18 E6/E7 DNA 疫苗接种后的免疫反应、治疗性抗肿瘤效果和耐受性

期刊:mBio

影响因子:4.7

doi:10.1128/mbio.02121-23

Peng, Shiwen; Tu, Hsin-Fang; Cheng, Michelle; Hu, Ming-Hung; Tsai, Hua-Ling; Tsai, Ya-Chea; Koenig, Chelsea; Brayton, Cory; Wang, Hao; Chang, Yung-Nien; Arend, Rebecca C; Levinson, Kimberly; Roden, Richard B S; Wu, T C; Hung, Chien-Fu

Safety Run-in of Intramuscular pNGVL4a-Sig/E7(detox)/HSP70 DNA and TA-CIN Protein Vaccination as Treatment for HPV16+ ASC-US, ASC-H, or LSIL/CIN1

肌注 pNGVL4a-Sig/E7(detox)/HSP70 DNA 和 TA-CIN 蛋白疫苗治疗 HPV16+ ASC-US、ASC-H 或 LSIL/CIN1 的安全性研究

期刊:Cancer Prevention Research

影响因子:2.6

doi:10.1158/1940-6207.CAPR-22-0413

Einstein, Mark H; Roden, Richard B S; Ferrall, Louise; Akin, Mark; Blomer, Allison; Wu, T C; Chang, Yung-Nien

Personalizing DNA Cancer Vaccines

个性化DNA癌症疫苗

A randomized pilot study of HPV16 L2E7E6 fusion protein vaccination site post-treatment for HPV16+ cervical cancer

一项关于HPV16 L2E7E6融合蛋白疫苗接种部位治疗后HPV16阳性宫颈癌的随机试点研究

Molecular targets and strategies in the development of nucleic acid cancer vaccines: from shared to personalized antigens

核酸癌症疫苗研发中的分子靶点和策略：从共享抗原到个性化抗原

Arginine-linked HPV-associated E7 displaying bacteria-derived outer membrane vesicles as a potent antigen-specific cancer vaccine

精氨酸连接的HPV相关E7蛋白展示细菌来源的外膜囊泡，作为一种强效的抗原特异性癌症疫苗

Salmonella immunotherapy engineered with highly efficient tumor antigen coating establishes antigen-specific CD8+ T cell immunity and increases in antitumor efficacy with type I interferon combination therapy

采用高效肿瘤抗原包被的沙门氏菌免疫疗法可建立抗原特异性CD8+ T细胞免疫，并增强与I型干扰素联合疗法的抗肿瘤疗效。

Uterine MEIS1::NCOA2 Fusion Sarcoma With Lung Metastasis: A Case Report and Review of the Literature

子宫MEIS1::NCOA2融合肉瘤伴肺转移：病例报告及文献复习

Sidedness and addition of chemotherapy associated with treatment outcomes of regorafenib for metastatic colorectal cancer: a population-wide cohort study

转移性结直肠癌瑞戈非尼治疗结果与肿瘤侧别及是否联合化疗的相关性：一项基于人群的队列研究

Profiling of VEGF Receptors and Immune Checkpoints in Recurrent Respiratory Papillomatosis

复发性呼吸道乳头状瘤病中 VEGF 受体和免疫检查点的分析

Immune responses, therapeutic anti-tumor effects, and tolerability upon therapeutic HPV16/18 E6/E7 DNA vaccination via needle-free biojector

通过无针生物注射器进行治疗性 HPV16/18 E6/E7 DNA 疫苗接种后的免疫反应、治疗性抗肿瘤效果和耐受性

Safety Run-in of Intramuscular pNGVL4a-Sig/E7(detox)/HSP70 DNA and TA-CIN Protein Vaccination as Treatment for HPV16+ ASC-US, ASC-H, or LSIL/CIN1

肌注 pNGVL4a-Sig/E7(detox)/HSP70 DNA 和 TA-CIN 蛋白疫苗治疗 HPV16+ ASC-US、ASC-H 或 LSIL/CIN1 的安全性研究